CollPlant, Stratasys Explore 3D-Printed Breast Implants
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
The device combines tumescent local anesthesia infiltration, power-assisted tissue removal, and aspiration into a single platform.